Login / Signup

Telehealth in oncology: a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial.

Marliese AlexanderIan M CollinsPatrick AbrahamUnderhill CraigSam HarrisJavier TorresSharad SharmaBenjamin SolomonAn Tran-DuyKate Burbury
Published in: Internal medicine journal (2024)
This cost analysis, from a societal perspective, compared the cost difference of a networked teletrial model (NTTM) with four regional hubs versus conventional trial operation at a single metropolitan specialist centre. The Australian phase 3 cancer interventional randomised controlled trial included 152 of 328 regional participants (patient enrolment 2018-2021; 6-month primary end point). The NTTM significantly reduced (AU$2155 per patient) patient travel cost and time and lost productivity.
Keyphrases
  • clinical trial
  • study protocol
  • case report
  • papillary thyroid
  • phase iii
  • palliative care
  • squamous cell
  • climate change
  • healthcare
  • gold nanoparticles
  • double blind
  • affordable care act